sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
28-Aug-2016 10:04
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 751-775 out of 1298.

<< < 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 > >>

Public Release: 29-Jun-2015
Proceedings of the National Academy of Sciences
First-ever possible treatments for MERS
As the South Korean MERS epidemic continues, researchers have discovered and validated two therapeutics that show early promise in preventing and treating the disease, which can cause severe respiratory symptoms, and has a death rate of 40 percent.

Contact: David Kohn
University of Maryland School of Medicine

Public Release: 29-Jun-2015
Biological Chemistry
OU professor developing vaccine to protect global communities from malaria
An OU professor studying malaria mosquito interaction has discovered a new mosquito protein for the development of a vaccine that is expected to stop the spread of the disease in areas where it is considered endemic. Malaria is transmitted by mosquitoes, and it infects millions of people in Africa, Asia and South America every year, causing a global health crisis. Local populations, US military personnel stationed in these areas and travelers to these malaria-prone areas are at risk of becoming infected.
National Institutes of Health, National Science Foundation, Oklahoma Center for the Advancement of Science and Technology

Contact: Jana Smith
University of Oklahoma

Public Release: 29-Jun-2015
SLU's vaccine center awarded $2.9 million to study new TB vaccine
Daniel Hoft, M.D., Ph.D., director of the division of infectious diseases at Saint Louis University has received funding from the Gates Foundation to research a potential vaccine against tuberculosis.
Bill & Melinda Gates Foundation

Contact: Nancy Solomon
Saint Louis University

Public Release: 29-Jun-2015
PLOS Pathogens
TSRI and biotech partners find new antibody weapons against Marburg virus
A new study led by scientists at the Scripps Research Institute identifies new immune molecules that protect against deadly Marburg virus, a relative of Ebola virus. The research provides ingredients needed to develop treatments for future Marburg outbreaks.
NIH/National Institute of Allergy and Infectious Diseases, National Science Foundation, Japan Society for Promotion of Science, Uehara Memorial Foundation, Investigators in the Pathogenesis of Infectious Disease etc.

Contact: Madeline McCurry-Schmidt
Scripps Research Institute

Public Release: 28-Jun-2015
Lancet Global Health
More secondary schooling reduces HIV risk
Longer secondary schooling substantially reduces the risk of HIV infection -- especially for girls -- and could be a very cost-effective way to halt the spread of the virus, according to researchers from Harvard T.H. Chan School of Public Health. In a study in Botswana, researchers found that, for each additional year of secondary school, students lowered their risk of HIV infection by 8 percentage points about a decade later, from 25 percent to about 17 percent infected.
Harvard T.H. Chan School of Public Health, Belgian American Educational Foundation, Fernand Lazard Foundation, Boston University, National Institutes of Health

Contact: Marge Dwyer
Harvard T.H. Chan School of Public Health

Public Release: 26-Jun-2015
Cell Reports
Scientists identify 'decoy' molecule that could help sharply reduce risk of flu death
The flu virus can be lethal. But what is often just as dangerous is the body's own reaction to the invader. The immune counterattack can end up harming the body's own tissues, causing deadly damage. Now, a University of Maryland School of Medicine researcher has for the first time uncovered new details about how this response plays out. And he has identified a 'decoy' molecule that can rein in this runaway inflammatory response.

Contact: David Kohn
University of Maryland School of Medicine

Public Release: 25-Jun-2015
Proceedings of the Royal Society B
Tracking the genetic arms race between humans and mosquitoes
Individual populations of mosquitoes are under strong evolutionary pressure from humans and their environment, a new study shows.
National Institutes of Health, Russian Science Ministry

Contact: Robert Perkins
University of Southern California

Public Release: 25-Jun-2015
University of Kentucky researcher to develop artificial blood for mosquitoes
A University of Kentucky professor's laboratory continues to advance research on controlling one of the world's most notorious species of pests, the mosquito.
Bill and Melinda Gates Foundation

Contact: Katie Pratt
University of Kentucky

Public Release: 25-Jun-2015
New report: Investments in neglected tropical diseases one of the best buys in development
A new report by Uniting to Combat NTDs highlights dramatic health and economic benefits from investing in combating neglected tropical diseases, making it one of the best buys in development. The report finds that countries are increasingly taking ownership of NTD programs, have started providing new funding and are pursuing innovative approaches to combat these devastating diseases. Yet, further scale-up is necessary to reach the World Health Organization 2020 targets.
Uniting to Combat Neglected Tropical Diseases

Contact: Dan Pawson
Global Health Strategies

Public Release: 25-Jun-2015
Veterinary Record
European rule changes on cross border pet transport may heighten rabies risk
Recent changes to regulations on the transport of pets across Europe may have increased the threat of introducing rabies from rescue dogs into countries considered free of the disease, suggests research published in Veterinary Record.

Contact: Caroline White

Public Release: 25-Jun-2015
Cell Host & Microbe
New target identified for inhibiting malaria parasite invasion
A new study led by researchers at Harvard T.H. Chan School of Public Health finds that a malaria parasite protein called calcineurin is essential for parasite invasion into red blood cells.
National Institutes of Health, American Cancer Society

Contact: Todd Datz
Harvard T.H. Chan School of Public Health

Public Release: 25-Jun-2015
Rapid Ebola diagnostic successful in field trial
A new test can accurately diagnose Ebola virus disease within minutes at the point of care.
Abundance Foundation

Contact: David Cameron
Harvard Medical School

Public Release: 25-Jun-2015
Cell Reports
TSRI team gets new close-up view of key part of Ebola virus life cycle
A new study led by scientists at the Scripps Research Institute reveals a key part of the Ebola virus life cycle at a higher resolution than ever before. The research sheds light on how Ebola virus assembles -- and how researchers might stop the often-fatal infection.
Skaggs Institute of Chemical Biology, Burroughs Wellcome Fund, National Institutes of Health, NIH/National Cancer Institute, NIH/National Institute of General Medical Sciences, Advanced Photon Source

Contact: Madeline McCurry-Schmidt
Scripps Research Institute

Public Release: 25-Jun-2015
PLOS Pathogens
Targeted nanoparticles can overcome drug resistance in trypanosomes
Sleeping sickness threatens millions of people in sub-Saharan Africa. The disease is considered fatal if untreated, but treatment options are limited. Existing drugs have serious side effects, and the parasites are developing resistance. A study published on June 25 in PLOS Pathogens reports a new way to circumvent drug resistance and lower the curative dose by delivering existing drugs directly into the parasite, a high-tech approach with potential applications to other infectious diseases.

Contact: Jose Garcia-Salcedo

Public Release: 24-Jun-2015
Three Ebola virus variants identified in Guinea
Sequencing the genome of Ebola virus strains circulating in Guinea has allowed scientists at the Institut Pasteur in Dakar and in Paris, the CNRS and the University of Sydney to retrace the spread of the virus and monitor its evolution in the country where the outbreak started. Characterization of the genetic variations of the virus is crucial to ensure the continued efficacy of diagnostic tools and for the development of effective treatments and vaccines.

Contact: Aurelie Perthuison / Myriam Rebeyrotte
Institut Pasteur

Public Release: 23-Jun-2015
Shining a stochastic spotlight on Ebola
Lehigh engineers were recently awarded a one-year Collaborative Research (CORE) Grant from the University to apply stochastic modeling to the spread of Ebola. Their goal is to use the model to develop more effective methods of predicting, mapping and responding to disease outbreaks and natural disasters, and to expand their collaboration in the long term to include social scientists and economists.
Lehigh University Collaborative Research (CORE) Grant

Contact: Jordan Reese
Lehigh University

Public Release: 23-Jun-2015
PLOS Medicine
Multidrug-resistant TB appears less transmissible in households than drug-susceptible TB
Some strains of multidrug-resistant tuberculosis (MDRTB) may have a lower fitness (be less capable of spreading) than drug-susceptible tuberculosis bacteria, according to a study published this week in PLOS Medicine. The study, conducted by Louis Grandjean of Imperial College London, and colleagues, compared new tuberculosis cases among household contacts of tuberculosis patients in South Lima and Callao, Peru, to determine the relative fitness of MDRTB vs. drug-susceptible tuberculosis.

Contact: Press Office

Public Release: 22-Jun-2015
Study looks at antibiotic choice for treating childhood pneumonia
New Vanderbilt-led research shows hospitals are doing a better job of using antibiotics less commonly associated with antibiotic resistance to treat children hospitalized with community-acquired pneumonia (CAP).
Center for Disease Control and Prevention's Influenza Division of the National Center for Immunization and Respiratory Diseases

Contact: Matt Batcheldor
Vanderbilt University Medical Center

Public Release: 19-Jun-2015
PLOS Biology
How to wipe out polio and prevent its re-emergence
Public health officials stand poised to eliminate polio from the planet. But a new study shows that the job won't be over when the last case of the horrible paralytic disease is recorded.
Advanced Research Computing at U-M, UAF Life Science Informatics

Contact: Jim Erickson
University of Michigan

Public Release: 18-Jun-2015
Earth Institute Director Jeffrey Sachs awarded Blue Planet Prize
Jeffrey Sachs, director of Columbia University's Earth Institute, has been awarded the 2015 Blue Planet Prize. The prize is presented each year to two individuals or organizations worldwide to recognize major efforts to solve global environmental problems. The other recipient this year is Cambridge University economist emeritus Sir Partha Dasgupta. The prize is given by Japan's Asahi Glass Foundation.

Contact: Kevin Krajick
The Earth Institute at Columbia University

Public Release: 18-Jun-2015
Sequencing Ebola's secrets
A global team from Harvard University, the Broad Institute, the US Centers for Disease Control and Prevention, and the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, along with many other institutions, sequenced more than 200 additional genomes from Ebola virus samples, to capture the fullest picture yet of how the virus is transmitted and how it has changed over the long-term outbreak.

Contact: Peter Reuell
Harvard University

Public Release: 17-Jun-2015
New England Journal of Medicine
Massachusetts General Hospital physicians write of their experiences in Nepal earthquake relief
Two Massachusetts General Hospital physicians who participated in the international response to the major earthquakes that hit Nepal in April and May each describe their experiences in Perspectives articles receiving Online First publication today in the New England Journal of Medicine.

Contact: Mike Morrison
Massachusetts General Hospital

Public Release: 17-Jun-2015
Study of Ebola survivors opens in Liberia
The Liberia-US clinical research partnership known as PREVAIL has launched a study of people in Liberia who have survived Ebola virus disease (EVD) within the past two years. The clinical trial investigators hope to better understand the long-term health consequences of EVD, determine if survivors develop immunity that will protect them from future Ebola infection, and assess whether previously EVD-infected individuals can transmit infection to close contacts and sexual partners.
NIH/National Institute of Allergy and Infectious Diseases, Ministry of Health of Liberia

Contact: Jennifer Routh
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 17-Jun-2015
Changes in HIV genetic code determine severity of disease
In a finding that furthers the understanding of human immunodeficiency virus (HIV), researchers from Children's Hospital Los Angeles discovered two locations where a single difference in HIV's genetic code altered the way the virus infected the cell, thereby influencing the progression of the disease.
NIH/National Institute of Child Health and Development, International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Contact: Ellin Kavanagh
Children's Hospital Los Angeles

Public Release: 16-Jun-2015
European Conferences on Biomedical Optics 2015
Journal of Biomedical Optics
Journal article details 'multiplicity of barriers' to clinical acceptance of medical laser innovations
An article published today in the Journal of Biomedical Optics details obstacles along the path from idea to clinical use of life-saving new medical laser applications. The article appears in a special section titled 'Light for Life' celebrating the International Year of Light and Light-based Technologies 2015 and paralleling a dedicated session at the at the European Conference on Biomedical Optics running June 21-25 in Munich.

Contact: Amy Nelson
SPIE--International Society for Optics and Photonics

Showing releases 751-775 out of 1298.

<< < 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 > >>